Key result
Continuous positive airway pressure treatment for 12 months significantly reduced resting muscle sympathetic nerve activity from 54.2 to 38.0 bursts/min and restored brainstem structure and function in patients with obstructive sleep apnea.
Why the study?
Does continuous positive airway pressure (CPAP) treatment reduce muscle sympathetic nerve activity and restore brainstem function and structure in patients with obstructive sleep apnea?
Cohort (n=30)
No
Does continuous positive airway pressure (CPAP) treatment reduce muscle sympathetic nerve activity and restore brainstem function and structure in patients with obstructive sleep apnea?
Absolute Event Rate: 38% vs 54.2%
p-value: p=<0.0001
Long-term CPAP treatment in OSA patients effectively reduces elevated muscle sympathetic nerve activity and restores related brainstem structure and function, potentially mitigating future cardiovascular risk.
Muscle sympathetic nerve activity (MSNA) is greatly elevated in patients with obstructive sleep apnea (OSA) during normoxic daytime wakefulness. Increased MSNA is a precursor to hypertension and elevated cardiovascular morbidity and mortality. However, the mechanisms underlying the high MSNA in OSA are not well understood. In this study we used concurrent microneurography and magnetic resonance imaging to explore MSNA-related brainstem activity changes and anatomical changes in 15 control and 15 OSA subjects before and after 6 and 12 months of continuous positive airway pressure (CPAP) treatment. We found that following 6 and 12 months of CPAP treatment, resting MSNA levels were significantly reduced in individuals with OSA. Furthermore, this MSNA reduction was associated with restoration of MSNA-related brainstem activity and structural changes in the medullary raphe, rostral ventrolateral medulla, dorsolateral pons, and ventral midbrain. This restoration occurred after 6 months of CPAP treatment and was maintained following 12 months CPAP. These findings show that continual CPAP treatment is an effective long-term treatment for elevated MSNA likely due to its effects on restoring brainstem structure and function.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2016) conducted a cohort in Obstructive Sleep Apnea (n=30). Continuous Positive Airway Pressure (CPAP) vs. Baseline (pre-CPAP) was evaluated on MSNA burst frequency (bursts/min) (p=<0.0001). Continuous positive airway pressure treatment for 12 months significantly reduced resting muscle sympathetic nerve activity from 54.2 to 38.0 bursts/min and restored brainstem structure and function in patients with obstructive sleep apnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: